A joint paper with Kuma Hospital, one of the leading thyroid hospitals in Japan, was published in Endocrine Journal, a publication of the Japanese Endocrine Society.
According to this paper, 57.1% of the cases that were found to be inappropriate or unknown in the rapid adequacy assessment of thyroid gland by naked eyes were confirmed to have cells by using Mobile Rose and were considered appropriate.
The clinical utility of Mobile Rose has been shown to prevent unnecessary re-sampling.
For more information, please click on the link below.
[PDF]Kuma Hospital MRPaper(3.5MB)
March 26, 2021, “The Ministry of Economy, Trade and Industry (METI) has announced that it will “support the challenges of small and medium-sized enterprises (SMEs) that are willing to undertake drastic business restructuring, such as expansion into new fields, change of business category, change of business or industry, business restructuring, or expansion of scale through these initiatives.Our project using MOBILE ROSE (development and market deployment of MOBILE ROSE, the world’s first microscope that supports rapid on site evaluation) was adopted.
After the debut of our booth at the 59th Annual Meeting of the Japanese Society for Clinical Cytology in 2020, we received requests from researchers who were very interested in ROSE to reserve a demo unit.
Mobile Rose was registered as controlled medical devices requiring special maintenance (12B2X10031000001) on April 26, 2021.
Mobile Rose was registered as a patent on April 14,
2021 under the title of Microscope Apparatus.
The Japanese Society of Clinical Cytology (JSCC) has issued the following recommendations regarding ROSE in coronavirus pandemic.
In principle, the presence of COVID-19 infection itself does not preclude the use of ROSE, but it may be used only when the advantages from a medical standpoint outweigh the disadvantages, and when adequate protection can be provided.
In principle, the tests should be conducted when there is adequate reserve for protective clothing, and when it is necessary to conduct the tests immediately.
In municipalities where a state of emergency has been declared, consideration should be given to suspending the implementation of non-urgent cases in order to limit the flow of people.
(Reference: The official website of the Japanese Society of Clinical Cytology)
“Consideration of practicality of Mobile Rose in Thyroid Puncture Aspiration Cytology.”
LBC cytology with BD CytoRichTM Red Preservative,
the accuracy of the Mobile Rose test is high, with sensitivity (94.6%), specificity (100%), and positive predictive value (100%),
useful for rapid determination of FNA materials on-site, operation time 90.1 seconds, effective for rapid evaluation of specimens.
Determination can be made without the need for a pathologist or cytotechnologist. High false negative rate (42.9%), difficulty in recognizing small cell clusters.
Above points were presented as a result of the verification.
(Source: Poster presentation by Dr. Toshitetsu Hayashi)
We had the first unveiling of the exhibit at Pacifico Yokohama North on November 21-22, 2020.
This year, due to the COVID-19 pandemic, the event was held as a hybrid with the web, and the overall number of visitors was less than usual.
Nevertheless, we had a lot of interest in our booth from doctors, and we even received rental demo units requests.
This was the debut of Mobile Rose at the conference, and it was a two-day event that convinced us of the high demand and potential of Mobile Rose in the industry.
We sincerely appreciate that all.
For Mobile Rose reservation, or inquiries, please contact us anytime using the contact form.
The 59th Annual Autumn Meeting of the Japanese Society of Clinical Cytology
<Theme> “The True Value and Evolution of Cytology”
<Date> Saturday, November 21, and Sunday, November 22, 2020
<Venue>Pacifico Yokohama North
1-1-2 Minatomirai, Nishi-ku, Yokohama City, Kanagawa 220-0012, Japan
Yamachu Corporation’s booth No.23 will be located in the Multipurpose Hall G7/G8.
We look forward to seeing you there.